Published on 22/12/2025
Checklist for Preparing Informed Consent Documents for Ethics Committee Submissions
The Informed Consent Form (ICF) is a core document in any clinical trial submission to an Ethics Committee (EC). It provides participants with all necessary information to make an informed decision about trial participation. ECs rigorously review ICFs to ensure ethical compliance, participant comprehension, and regulatory adherence. This article provides a comprehensive checklist and guide to prepare ICFs that meet EC expectations and avoid delays in approval.
Why the Informed Consent Form Is Critical:
- Ensures participants understand study procedures, risks, and rights
- Acts as a legal and ethical safeguard
- Directly influences EC approval timelines and study start-up
According to EMA and CDSCO guidelines, the ICF must be understandable, comprehensive, and adapted to the target population.
ICF Compliance Checklist for EC Submissions:
1. Administrative Details
- Study title and protocol number
- Version number and version date (e.g., V2.0, 20-June-2025)
- Site and investigator details (with institutional logo if required)
2. Introduction to the Study
- Clear statement that this is a clinical research study
- Purpose of the study explained in layperson terms
- Voluntary nature of participation emphasized
3. Study Procedures
- Overview of participant activities, duration, and number of visits
- Explanation of any randomization or blinding
- Type of
4. Risks and Discomforts
- Clearly list potential side effects or discomforts
- Include both common and rare risks associated with participation
- State unknown risks if applicable
5. Potential Benefits
- Clarify whether participants will benefit directly or if benefits are societal
- Avoid overstating therapeutic potential
6. Alternatives to Participation
Describe available alternative treatments or procedures if participant chooses not to enroll.
7. Confidentiality and Data Handling
- Explain who will access data and how confidentiality will be maintained
- Include data storage duration and anonymization policies
- Comply with GMP documentation and data protection norms (e.g., GDPR)
8. Voluntary Participation and Withdrawal
- Participant has right to withdraw at any time
- Clarify there will be no penalty or loss of benefits
9. Compensation and Medical Care
- Clearly explain compensation for trial-related injury
- Include details of medical management and insurance coverage
- Mention compensation policy per regulatory guidelines
10. Contact Information
- Name and phone number of principal investigator
- EC contact details for participant concerns or queries
11. Signature Section
- Separate signature lines for participant, investigator, and witness
- Signature dates must be included
- If applicable, include legal representative or LAR (Legally Authorized Representative)
12. Language and Readability
- Use simple, non-technical language
- Translate into local language as required
- Provide back-translation certificates to EC
- Recommended readability level: Grade 6 or lower
Additional Considerations:
1. Multilingual Versions
- All translations must match the English master
- Use certified translators and back-translation methods
2. Special Populations
- For pediatric studies, include assent forms and parent consent
- For illiterate participants, provide an impartial witness
3. Version Control
- Track all changes with updated version numbers and date
- Use audit-ready formats with clean and tracked change versions
Organize ICFs in submission folders aligned with stability studies and protocol-related documents for consistency.
Common EC Deficiencies Related to ICFs:
- Overly complex language or jargon
- Missing details on compensation or insurance
- Signature boxes not matching participant names
- Incorrect version numbers or incomplete translations
Sample ICF Submission Package to EC:
- English Master ICF (clean and tracked)
- Local Language ICF(s)
- Back-translation certificate(s)
- ICF Version Control Log
- ICF Checklist signed by QA/Regulatory personnel
- ICF Review SOP reference
Tips to Avoid EC Delays:
- Follow EC-specific ICF templates if provided
- Submit both soft and hard copies as per EC policy
- Ensure document formatting: font size ≥12 pt, line spacing ≥1.5
- Keep each ICF ≤6–8 pages wherever possible
Conclusion:
A robust, readable, and compliant Informed Consent Form significantly improves your chances of Ethics Committee approval. By using this checklist and adhering to regulatory and EC-specific expectations, you ensure ethical clarity for participants while avoiding resubmissions and costly delays. Document all changes, validate translations, and maintain centralized version control to stay EC-ready at all times.